258 related articles for article (PubMed ID: 32006068)
21. Pharyngeal Constrictor Dose-Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy.
Paetkau O; Weppler S; Kwok J; Quon HC; Gomes da Rocha C; Smith W; Tchistiakova E; Kirkby C
Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):173-182. PubMed ID: 38220581
[TBL] [Abstract][Full Text] [Related]
22. Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
Mierzwa ML; Gharzai LA; Li P; Wilkie JR; Hawkins PG; Aryal MP; Lee C; Rosen B; Lyden T; Blakely A; Chapman CH; Thamarus J; Schonewolf C; Shah J; Eisbruch A; Schipper MJ; Cao Y
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):566-573. PubMed ID: 33346093
[TBL] [Abstract][Full Text] [Related]
23. Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation.
Tsai CJ; Jackson A; Setton J; Riaz N; McBride S; Leeman J; Kowalski A; Happersett L; Lee NY
JCO Clin Cancer Inform; 2017 Nov; 1():1-7. PubMed ID: 30657398
[TBL] [Abstract][Full Text] [Related]
24. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
[TBL] [Abstract][Full Text] [Related]
25. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis.
Jiang L; Huang C; Gan Y; Wu T; Tang X; Wang Y; Wang R; Zhang Y
Sci Rep; 2018 Nov; 8(1):16396. PubMed ID: 30401941
[TBL] [Abstract][Full Text] [Related]
27. [Head and neck intensity-modulated radiation therapy: Normal tissues dose constraints. Pharyngeal constrictor muscles and larynx].
Graff P; Woisard V; Racadot S; Thariat J; Pointreau Y
Cancer Radiother; 2016 Oct; 20(6-7):452-8. PubMed ID: 27599684
[TBL] [Abstract][Full Text] [Related]
28. Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.
Kil WJ; Kulasekere C; Hatch C; Bugno J; Derrwaldt R
Head Neck; 2017 Aug; 39(8):E85-E91. PubMed ID: 28475284
[TBL] [Abstract][Full Text] [Related]
29. Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.
Truong MT; Lee R; Saito N; Qureshi MM; Ozonoff A; Romesser PB; Wang J; Sakai O
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e119-27. PubMed ID: 21669502
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
[TBL] [Abstract][Full Text] [Related]
31. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
[TBL] [Abstract][Full Text] [Related]
32. Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
Amin N; Reddy K; Westerly D; Raben D; DeWitt P; Chen C
Laryngoscope; 2012 Dec; 122(12):2736-42. PubMed ID: 22991101
[TBL] [Abstract][Full Text] [Related]
33. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison.
Awan MJ; Mohamed AS; Lewin JS; Baron CA; Gunn GB; Rosenthal DI; Holsinger FC; Schwartz DL; Fuller CD; Hutcheson KA
Oral Oncol; 2014 Aug; 50(8):746-52. PubMed ID: 24906528
[TBL] [Abstract][Full Text] [Related]
34. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
[TBL] [Abstract][Full Text] [Related]
35. Sparing Swallowing-Related Structures Reduces Post-Radiotherapy Dysphagia in Oropharyngeal Cancer.
Wasuthalainun C; Keskool P; Petsuksiri J; Ongard S; Sureepong P
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1451-1456. PubMed ID: 38680007
[TBL] [Abstract][Full Text] [Related]
36. Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer.
Maurer J; Hipp M; Schäfer C; Kölbl O
Strahlenther Onkol; 2011 Nov; 187(11):744-9. PubMed ID: 22037655
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer.
Yamic F; Koca T; Tuncel N; Aksoy RA; Korcum AF
Technol Cancer Res Treat; 2024; 23():15330338241260646. PubMed ID: 38841792
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
40. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences.
Eisbruch A; Levendag PC; Feng FY; Teguh D; Lyden T; Schmitz PI; Haxer M; Noever I; Chepeha DB; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S40-2. PubMed ID: 17848291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
